We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App





Abbott’s Panbio COVID-19 Ag Rapid Test Receives WHO Clearance for Emergency Use Listing

By LabMedica International staff writers
Posted on 06 Oct 2020
Abbott’s (Lake Forest, IL, USA) Panbio COVID-19 Ag Rapid Test has become the second rapid antigen test to be approved by the World Health Organization (WHO) for emergency use listing.

On September 22, the WHO had approved the first COVID-19 rapid test produced by SD Biosensor (Korea). More...
WHO records now show that the second rapid test to be cleared for emergency use listing is the Panbio COVID-19 Ag Rapid Test made by Abbott. Designed to scale up COVID-19 antigen testing and meant for patients suspected of current COVID-19 infection, the test requires no instrumentation and provides results in 15 minutes, making it a valuable tool for mass testing in decentralized settings.

The kit contains a self-contained tube with "break off" swab to minimize staff exposure and a fully enclosed extraction tube for disposal. The Panbio COVID-19 Ag Rapid Test has a sensitivity of 93.3% and specificity of 99.4%

Abbott’s Panbio COVID-19 Ag Rapid Test provides an accessible, portable and scalable option for COVID-19 testing and can be deployed at point of care in a variety of settings. The test may also be useful for supporting public health strategies, such as contact tracing and large-scale testing of people suspected of having an active infection.



Platinum Member
Fully Automatic ACLIA Analyzer
MAGLUMI X8
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Automated Clinical Chemistry Analyzer
Envoy 500+
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.